LU88684I2 - Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet ) - Google Patents

Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet )

Info

Publication number
LU88684I2
LU88684I2 LU88684C LU88684C LU88684I2 LU 88684 I2 LU88684 I2 LU 88684I2 LU 88684 C LU88684 C LU 88684C LU 88684 C LU88684 C LU 88684C LU 88684 I2 LU88684 I2 LU 88684I2
Authority
LU
Luxembourg
Prior art keywords
lipid
compositions
amphotericin
abelcet
pharmaceutically acceptable
Prior art date
Application number
LU88684C
Other languages
English (en)
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27361805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU88684(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of LU88684I2 publication Critical patent/LU88684I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03B—APPARATUS OR ARRANGEMENTS FOR TAKING PHOTOGRAPHS OR FOR PROJECTING OR VIEWING THEM; APPARATUS OR ARRANGEMENTS EMPLOYING ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ACCESSORIES THEREFOR
    • G03B2227/00—Photographic printing apparatus
    • G03B2227/32—Projection printing apparatus, e.g. enlarging apparatus, copying camera
    • G03B2227/325—Microcapsule copiers
LU88684C 1987-03-05 1988-03-04 Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet ) LU88684I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2215787A 1987-03-05 1987-03-05
US6990887A 1987-07-06 1987-07-06
US7930987A 1987-07-29 1987-07-29

Publications (1)

Publication Number Publication Date
LU88684I2 true LU88684I2 (fr) 1996-04-29

Family

ID=27361805

Family Applications (1)

Application Number Title Priority Date Filing Date
LU88684C LU88684I2 (fr) 1987-03-05 1988-03-04 Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet )

Country Status (20)

Country Link
EP (1) EP0282405B2 (fr)
KR (1) KR970002870B1 (fr)
CN (1) CN1044093C (fr)
AT (1) ATE118169T1 (fr)
AU (1) AU622405B2 (fr)
CA (1) CA1338701C (fr)
DE (1) DE3852961T3 (fr)
DK (1) DK176010B1 (fr)
ES (1) ES2070131T5 (fr)
FI (1) FI102724B1 (fr)
GR (1) GR3015916T3 (fr)
HK (1) HK1007495A1 (fr)
IE (1) IE67152B1 (fr)
IL (1) IL85607A (fr)
LU (1) LU88684I2 (fr)
NL (1) NL990004I1 (fr)
NO (4) NO179995C (fr)
NZ (1) NZ223660A (fr)
PT (1) PT86913B (fr)
WO (1) WO1988006443A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5830498A (en) * 1987-10-16 1998-11-03 Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
AU598958B2 (en) * 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
AU638245B2 (en) * 1989-03-31 1993-06-24 Regents Of The University Of California, The Preparation of liposome and lipid complex compositions
US5188951A (en) * 1990-04-17 1993-02-23 The Liposome Company, Inc. Enzymatic synthesis of soluble phosphatides from phospholipids
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
DE4108903A1 (de) * 1990-08-06 1992-02-13 Nattermann A & Cie Pharmazeutisches produkt
EP0556392A4 (fr) * 1990-11-06 1994-03-17 Nippon Shinyaku Co Ltd Procede de production d'une emulsion grasse.
US5534502A (en) * 1990-11-06 1996-07-09 Nippon Shinyaku Co. Ltd. Process for producing fat emulsion
AU664857B2 (en) * 1991-08-14 1995-12-07 Sequus Pharmaceuticals, Inc. HIV-treatment method with low-toxicity amphotericin B
EP1118326A3 (fr) * 1993-05-21 2002-07-31 The Liposome Company, Inc. Réduction de réactions physiologiques indésirables induites par des liposomes
US5716526A (en) * 1994-01-14 1998-02-10 The Liposome Company, Inc. Method of separating materials from liposomes or lipid complexes
US5902604A (en) 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
GB2326337A (en) 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
US6165997A (en) * 1997-11-20 2000-12-26 Statens Serum Institut Phospholipids having antimicrobial activity with or without the presence of antimicrobials
JP2009519250A (ja) * 2005-12-08 2009-05-14 ワイス リポソーム組成物
KR101132626B1 (ko) * 2009-10-12 2012-04-02 주식회사 녹십자 난용성 약물의 전달을 위한 고밀도지단백 나노입자의 제조방법
KR101793101B1 (ko) 2010-08-20 2017-11-02 닥터 레디스 래보러토리즈 에스에이 인지질 데포
NZ608406A (en) 2010-10-22 2015-06-26 Reddy’S Lab Inc Dr Use of storage stable viscous phospholipid depot to treat wounds
CA2871821C (fr) 2012-05-10 2021-01-12 Painreform Ltd. Preparations de depot d'un anesthesiant local et procedes de preparation associes
US10799456B2 (en) 2015-06-15 2020-10-13 University Of Washington Multiple drug lipid nanoparticle composition and related methods for extended drug levels in blood and lymph tissue

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310506A (en) * 1979-02-22 1982-01-12 California Institute Of Technology Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4604376A (en) * 1982-04-21 1986-08-05 Research Corporation Enteric compounds and complexes
US4436746A (en) * 1982-09-30 1984-03-13 Ciba-Geigy Corporation Thromboxane synthetase inhibitory N-substituted-2-(1-imidazolyl)indoles
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration

Also Published As

Publication number Publication date
NO1998013I1 (no) 1998-03-25
CN1044093C (zh) 1999-07-14
CN88101864A (zh) 1988-09-28
HK1007495A1 (en) 1999-04-16
DE3852961T3 (de) 1998-12-24
NO1998012I1 (no) 1998-03-25
IL85607A (en) 1992-08-18
ES2070131T3 (es) 1995-06-01
IE880600L (en) 1988-09-05
FI102724B (fi) 1999-02-15
IE67152B1 (en) 1996-03-06
DK98089D0 (da) 1989-03-01
NO884391D0 (no) 1988-10-04
NO884391L (no) 1988-11-24
EP0282405B1 (fr) 1995-02-08
NO179995B (no) 1996-10-21
NZ223660A (en) 1990-11-27
DE3852961D1 (de) 1995-03-23
NO180147B (no) 1996-11-18
NO944071L (no) 1988-11-24
PT86913A (pt) 1989-03-30
DK176010B1 (da) 2005-11-28
EP0282405A3 (en) 1989-01-04
NO180147C (no) 1997-02-26
ATE118169T1 (de) 1995-02-15
KR890700341A (ko) 1989-04-24
NO179995C (no) 1997-01-29
CA1338701C (fr) 1996-11-12
GR3015916T3 (en) 1995-07-31
WO1988006443A1 (fr) 1988-09-07
EP0282405B2 (fr) 1998-07-22
AU1799088A (en) 1988-09-26
FI894161A0 (fi) 1989-09-04
EP0282405A2 (fr) 1988-09-14
ES2070131T5 (es) 1998-10-01
DK98089A (da) 1989-03-01
NL990004I1 (nl) 1999-04-01
DE3852961T2 (de) 1995-07-06
NO944071D0 (no) 1994-10-26
AU622405B2 (en) 1992-04-09
FI102724B1 (fi) 1999-02-15
IL85607A0 (en) 1988-08-31
KR970002870B1 (ko) 1997-03-12
PT86913B (pt) 1993-07-30

Similar Documents

Publication Publication Date Title
LU88684I2 (fr) Complexe lipidique d'amphotericine b ainsi que leurs dérivés pharmaceutiquement acceptables (abelcet )
ES2061094T3 (es) Un procedimiento para la obtencion de una formulacion para disminuir el deseo imperioso de alcohol (craving) en el tratamiento del alcoholismo cronico.
CA2301057A1 (fr) Procede permettant d'administrer un taxane liposomal encapsule
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
RU95105973A (ru) Способ снижения тяжести токсоплазмоза, фармацевтическая композиция, применение производных рифамицина для получения лекарственных препаратов для лечения токсоплазмоза
AU8687391A (en) Lithium treatment
DE3869010D1 (de) Miocamycin enthaltende pharmazeutische zusammensetzungen fuer die topische anwendung.
EG17992A (en) Preparation of a medicament for arthritis and theumatism
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
IT1247093B (it) Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
IT1262929B (it) Impiego terapeutico del monosialodiesosil ganglioside gm3 e derivati come agenti anti-angiogenici